Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03123939
Title Phase III B in Acute Lymphoblastic Leukemia
Recruitment Completed
Gender
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

B-cell acute lymphoblastic leukemia

Therapies

Tisagenlecleucel

Age Groups: child | adult
Covered Countries ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.